Par Drugs & Che.

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: INE04LG01015
  • NSEID: PAR
  • BSEID:
INR
82.47
-0.16 (-0.19%)
BSENSE

Apr 02

BSE+NSE Vol: 7616

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Mar'21
Dec'20
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is -4.45% vs 17.29% in Sep 2024

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is -32.97% vs 51.22% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is -38.43% vs 36.12% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is 40.00% vs 25.00% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has fallen from Sep 2024

Compare Half Yearly Results Of Par Drugs & Che. With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
54.71
0
54.71
Other Operating Income
0.00
0.00
0.00
Total Operating income
54.71
0
54.71
Raw Material Cost
21.71
0
21.71
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
0.35
0
0.35
Employee Cost
2.77
0
2.77
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
20.25
0.00
20.25
Total Expenditure (Excl Depreciation)
45.08
0
45.08
Operating Profit (PBDIT) excl Other Income
9.63
0.00
9.63
Other Income
2.32
0
2.32
Operating Profit (PBDIT)
11.95
0
11.95
Interest
0.07
0
0.07
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
11.88
0
11.88
Depreciation
1.84
0
1.84
Profit Before Tax
10.03
0
10.03
Tax
2.57
0
2.57
Provisions and contingencies
0.00
0
0.00
Profit After Tax
7.46
0
7.46
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
7.46
0
7.46
Equity Capital
12.30
0
12.30
Face Value
10.00
0
0.00
Reserves
94.13
0
94.13
Earnings per share (EPS)
6.07
0
6.07
Diluted Earnings per share
6.06
0
6.06
Operating Profit Margin (Excl OI)
17.60%
0%
0.00
17.60%
Gross Profit Margin
21.71%
0%
0.00
21.71%
PAT Margin
13.64%
0%
0.00
13.64%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 54.71 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -4.45% vs 17.29% in Sep 2024

Half Yearly - Standalone Net Profit
Standalone Net Profit 7.46 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -32.97% vs 51.22% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.63 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -38.43% vs 36.12% in Sep 2024

Half Yearly - Interest
Interest 0.07 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 40.00% vs 25.00% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.60%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has fallen from Sep 2024